ChapmanSW, DismukesWE, ProiaLA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis2008; 461801–12.
2.
LemosLB, SoofiM, AmirE. Blastomycosis and pregnancy. Ann Diagn Pathol2002; 6: 211–5.
3.
PursleyTJ, BlomquistIK, AbrahamJ, AndersenHF, BartleyJA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis1996; 22: 336–40.
4.
Bar-OzB, MorettiME, BishaiR, et al. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. Am J Obstet Gynecol2000; 183: 617–20.
5.
BriggsGG, FreemanRK, YaffeSJ. Drugs in pregnancy and lactation : a reference guide to fetal and neonatal risk. 9th ed.Baltimore: Lippincott, Williams & Wilkins, 2011.
6.
De SantisM, Di GianantonioE, CesariE, AmbrosiniG, StrafaceG, ClementiM. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. Drug Saf2009; 32: 239–44.
7.
MenegolaE, BrocciaML, Di RenzoF, GiaviniE. Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects. Reprod Toxicol2006; 22: 186–95.
8.
ChotmongkolV, SookprasertA. Itraconazole in cryptococcal meningitis in pregnancy: a case report. J Med Assoc Thai1992; 75: 606–8.